UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study

Clinical infectious diseases, 2023-04, Vol.76 (7), p.1225-1236

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of obesity on the exposure of long-acting cabotegravir and rilpivirine: a modelling study

Clinical infectious diseases, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

Clinical infectious diseases, 2011-12, Vol.53 (11), p.1130-1139

2011

Link zum Volltext

Verfügbarkeit prüfen

Plea for Standardized Reporting and Justification of Propensity Score Methods

Clinical infectious diseases, 2019-02, Vol.68 (4), p.710-711

2019

Link zum Volltext

Verfügbarkeit prüfen

Digging Out the Evidence-How Strong Is the IDSA Recommendation Against Antibiotic Prophylaxis in Basilar Skull Fracture and Cerebrospinal Fluid Leakage?

Clinical infectious diseases, 2018-04, Vol.66 (8), p.1319-1320

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2145-e2152

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study

Clinical infectious diseases, 2021-04, Vol.72 (8), p.1413-1421

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune Reconstitution in HIV-Infected Patients

Clinical infectious diseases, 2004-04, Vol.38 (8), p.1159-1166

2004

Link zum Volltext

Verfügbarkeit prüfen

Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of Human Immunodeficiency Virus Transmission in Men Who Have Sex With Men

Clinical infectious diseases, 2021-06, Vol.72 (12), p.2175-2183

2021

Link zum Volltext

Verfügbarkeit prüfen

High Mortality of Non-Fournier Necrotizing Fasciitis With Enterobacteriales: Time to Rethink Classification?

Clinical infectious diseases, 2019-06, Vol.69 (1), p.147-150

2019

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group

Clinical infectious diseases, 2022-07, Vol.74 (12), p.2266-2266

2022

Link zum Volltext

Verfügbarkeit prüfen

Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group

Clinical infectious diseases, 2022-04, Vol.74 (8), p.1468-1475

2022

Link zum Volltext

Verfügbarkeit prüfen

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/μL in HIV Type 1-Infected Individuals Receiving Potent Antiretroviral Therapy

Clinical infectious diseases, 2005-08, Vol.41 (3), p.361-372

2005

Link zum Volltext

Verfügbarkeit prüfen

Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE

Clinical infectious diseases, 2021-07, Vol.73 (2), p.195-202

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost Estimates for Human Immunodeficiency Virus (HIV) Care and Patient Characteristics for Health Resource Use From Linkage of Claims Data With the Swiss HIV Cohort Study

Clinical infectious diseases, 2019-02, Vol.68 (5), p.827-833

2019

Link zum Volltext

Verfügbarkeit prüfen

CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies

Clinical infectious diseases, 2021-07, Vol.73 (1), p.50-59

2021

Link zum Volltext

Verfügbarkeit prüfen

Is It Safe to Discontinue Primary Pneumocystis jiroveci Pneumonia Prophylaxis in Patients with Virologically Suppressed HIV Infection and a CD4 Cell Count <200 Cells/μL?

Clinical infectious diseases, 2010-09, Vol.51 (5), p.611-619

The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE)

2010

Link zum Volltext

Verfügbarkeit prüfen

Limitations in Study on Benefits of Clindamycin

Clinical infectious diseases, 2015-01, Vol.60 (2), p.323-323

2015

Link zum Volltext

Verfügbarkeit prüfen

Reply to Parienti

Clinical infectious diseases, 2009-02, Vol.48 (3), p.370-372

2009

Link zum Volltext

Verfügbarkeit prüfen

A Comment on Marschall et al

Clinical infectious diseases, 2011-10, Vol.53 (7), p.748-748

2011

Link zum Volltext

Verfügbarkeit prüfen

Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of HIV Transmission in MSM

Clinical infectious diseases, 2020-04

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

Clinical infectious diseases, 2014-01, Vol.58 (2), p.85-85

2014

Link zum Volltext

Verfügbarkeit prüfen

Less than 28 Days of Intravenous Antibiotic Treatment Is Sufficient for Suppurative Thrombophiebitis in Injection Drug Users

Clinical infectious diseases, 2008-03, Vol.46 (5), p.741

2008

Link zum Volltext

Verfügbarkeit prüfen

Acute Renal Failure on Immune Reconstitution in an HIV-Positive Patient with Miliary Tuberculosis

Clinical infectious diseases, 2004-02, Vol.38 (4), p.e32-e35

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

ThemaAdult

KollektionOxford Journals

Zeitschrift / SerieClinical Infectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford University Press Journals Current
(32)
Oxford Journals 2020 Medicine
(32)
EZB Electronic Journals Library
(32)
Journals@Ovid
(32)
NUS Single-Journal Subscriptions
(32)
Jstor Complete Legacy
(26)
MEDLINE
(13)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study

Effect of obesity on the exposure of long-acting cabotegravir and rilpivirine: a modelling study

Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

Plea for Standardized Reporting and Justification of Propensity Score Methods

Digging Out the Evidence-How Strong Is the IDSA Recommendation Against Antibiotic Prophylaxis in Basilar Skull Fracture and Cerebrospinal Fluid Leakage?

Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors

The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study

CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies

Immune Reconstitution in HIV-Infected Patients

Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of Human Immunodeficiency Virus Transmission in Men Who Have Sex With Men

High Mortality of Non-Fournier Necrotizing Fasciitis With Enterobacteriales: Time to Rethink Classification?

Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group

Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/μL in HIV Type 1-Infected Individuals Receiving Potent Antiretroviral Therapy

Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE

Cost Estimates for Human Immunodeficiency Virus (HIV) Care and Patient Characteristics for Health Resource Use From Linkage of Claims Data With the Swiss HIV Cohort Study

CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies

Is It Safe to Discontinue Primary Pneumocystis jiroveci Pneumonia Prophylaxis in Patients with Virologically Suppressed HIV Infection and a CD4 Cell Count <200 Cells/μL?

Limitations in Study on Benefits of Clindamycin

Reply to Parienti

A Comment on Marschall et al

Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of HIV Transmission in MSM

Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

Less than 28 Days of Intravenous Antibiotic Treatment Is Sufficient for Suppurative Thrombophiebitis in Injection Drug Users

Acute Renal Failure on Immune Reconstitution in an HIV-Positive Patient with Miliary Tuberculosis

Aktive Filter

Suchergebnisse filtern